Refoxy Pharma | Valuation, Funding Rounds & Stock Price | Caplight
Refoxy Pharma
Private
Cologne
Healthcare & Life Sciences Refoxy Website
Last Round
Seed
Dec 4, 2024
Total Funding Raised
$15.4M
Momentum
Top 25% of companies Caplight tracks
Company Overview
Refoxy Pharma is a biotechnology company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
drug discovery, biotechnology, idiopathic pulmonary fibrosis, IPF, small molecule, FOXO3, geroscience, longevity research, fibrosis, preclinical research, phenotypic screening, drug pipeline, biotech startup, longevity biotech, therapeutic candidate
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Refoxy Pharma Comparables
Compare Refoxy Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Isterian Biotech | 81% | Unlock |
| Oorja Bio, Inc. | 78% | Unlock |
| Mediar Therapeutics | 71% | Unlock |
| Comparable company | 50% | Unlock |
Refoxy Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 4, 2024 | Unlock | Unlock | Unlock | Unlock |
| Seed | Nov 30, 2022 | Unlock | Unlock | Unlock | Unlock |
| Seed | Aug 1, 2021 | Unlock | Unlock | Unlock | Unlock |
Key People
Founding team and executive leadership
Victor Bustos
Co-Founder and CEO
Refoxy Pharma Investors
| Investor | Rounds |
|---|---|
| NRW.Venture | Seed |
| Boehringer Ingelheim | Seed |
| NRW.Bank | Seed |
| Korify Capital | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
- May 11, 2026: Monthly visitors grew 300% MoM, reaching 977.
- Dec 4, 2024: $9.7M round led by Boehringer Ingelheim.
Refoxy Pharma Filings
| Typed | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|---|---|---|---|---|---|
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
- Is Refoxy Pharma a public or private company?
- What is the current stock price of Refoxy Pharma?
- How much is Refoxy Pharma worth (valuation)?
- Can I buy Refoxy Pharma stock?
- When was Refoxy Pharma's last funding round?
- Who are the main investors in Refoxy Pharma?
- Will Refoxy Pharma IPO soon?
- How can I track Refoxy Pharma secondary market activity?
Firmographic Details
Headquarters: Cologne
Employee Range: 12
Year Founded: 2020
Last Funding: Dec 4, 2024